Literature DB >> 3093115

Xeroderma pigmentosum variant and normal fibroblasts show the same response to the inhibition of DNA replication by benzo[a]pyrene-diol-epoxide-I.

M Cordeiro-Stone, J C Boyer, B A Smith, W K Kaufmann.   

Abstract

Xeroderma pigmentosum (XP) variant cells are characterized by an abnormal pattern of replication of DNA damaged by 254 nm radiation (u.v.). To see whether benzo[a]pyrene-diol-epoxide-I (BPDE-I) elicits the same response, we have compared the effects of u.v. and BPDE-I on DNA replication in XP variant and normal skin fibroblasts. Doses of u.v. that only affected replicon initiation in normal cells, inhibited DNA strand growth in the XP variant. These results were confirmed by measurements of the rate of growth of single-stranded nascent DNA in cells synchronized at the beginning of the S phase. Identical analyses using BPDE-I, however, indicated that the two cell types were equally sensitive to the inhibitions of both replicon initiation and DNA strand growth. These results indicate that the XP variant phenotype cannot be recognized in vitro by the pattern of response of fibroblasts to the inhibition of DNA replication by BPDE-I.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3093115     DOI: 10.1093/carcin/7.10.1783

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  3 in total

1.  Impaired translesion synthesis in xeroderma pigmentosum variant extracts.

Authors:  A M Cordonnier; A R Lehmann; R P Fuchs
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

2.  Rad18 regulates DNA polymerase kappa and is required for recovery from S-phase checkpoint-mediated arrest.

Authors:  Xiaohui Bi; Laura R Barkley; Damien M Slater; Satoshi Tateishi; Masaru Yamaizumi; Haruo Ohmori; Cyrus Vaziri
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

3.  Defective replication of psoralen adducts detected at the gene-specific level in xeroderma pigmentosum variant cells.

Authors:  R R Misra; J M Vos
Journal:  Mol Cell Biol       Date:  1993-02       Impact factor: 4.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.